HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joydeep Das Selected Research

Neoplasms (Cancer)

12/2023Corrigendum to "In vivo therapeutic evaluation of a novel bis-lawsone derivative against tumor following delivery using mesoporous silica nanoparticle based redox-responsive drug delivery system" [Mater. Sci. Eng. C (2021) 112142].
11/2023Chitosan-PEI passivated carbon dots for plasmid DNA and miRNA-153 delivery in cancer cells.
1/2023pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy.
6/2022Enhancement of anti-neoplastic effects of cuminaldehyde against breast cancer via mesoporous silica nanoparticle based targeted drug delivery system.
10/2021Metal-doped and hybrid carbon dots: A comprehensive review on their synthesis and biomedical applications.
7/2021In vivo therapeutic evaluation of a novel bis-lawsone derivative against tumor following delivery using mesoporous silica nanoparticle based redox-responsive drug delivery system.
12/2020Zinc oxide nanoparticles: A comprehensive review on its synthesis, anticancer and drug delivery applications as well as health risks.
11/2020Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency.
1/2020Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy.
7/2019Synthesis and biomedical applications of nanoceria, a redox active nanoparticle.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joydeep Das Research Topics

Disease

16Neoplasms (Cancer)
12/2023 - 11/2014
12Body Weight (Weight, Body)
01/2023 - 01/2009
9Breast Neoplasms (Breast Cancer)
12/2023 - 01/2017
5Hyperglycemia
05/2013 - 04/2010
5Liver Diseases (Liver Disease)
01/2013 - 06/2010
4Cardiotoxicity
11/2023 - 07/2011
3Wounds and Injuries (Trauma)
01/2024 - 12/2012
2Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 01/2017
2Lung Neoplasms (Lung Cancer)
01/2022 - 02/2016
2Carcinoma (Carcinomatosis)
07/2019 - 01/2014
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2015 - 06/2010
2Insulin Resistance
01/2015 - 05/2013
2Diabetes Mellitus
05/2013 - 01/2012
2Diabetes Complications
01/2013 - 12/2012
2Inflammation (Inflammations)
04/2012 - 01/2012
1Neoplasm Metastasis (Metastasis)
01/2022
1Rupture
09/2021
1Ascites
07/2019
1Nausea
09/2017
1Vomiting
09/2017
1Oliguria
09/2017
1Hemorrhage
09/2017
1Exanthema (Rash)
09/2017
1Thrombocytopenia (Thrombopenia)
09/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017
1Myocardial Infarction
01/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2017
1Virus Diseases (Viral Diseases)
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Hypoxia (Hypoxemia)
02/2016
1Male Infertility (Male Sterility)
09/2015
1Type 2 Diabetes Mellitus (MODY)
01/2015
1Neutropenia
01/2014

Drug/Important Bio-Agent (IBA)

10AntioxidantsIBA
10/2021 - 10/2008
10TaurineFDA Link
05/2013 - 10/2008
7Silicon Dioxide (Silica)FDA LinkGeneric
12/2023 - 11/2020
5Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 07/2011
5Insulin (Novolin)FDA Link
01/2015 - 06/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020 - 01/2009
3chrysinIBA
10/2023 - 01/2022
3Folic Acid (Vitamin M)FDA LinkGeneric
10/2023 - 11/2020
3Boronic AcidsIBA
06/2022 - 07/2019
3Acetaminophen (Paracetamol)FDA LinkGeneric
03/2010 - 01/2010
2lawsoneIBA
12/2023 - 07/2021
2Zinc OxideFDA Link
12/2023 - 07/2019
2QuercetinIBA
12/2023 - 07/2019
2salvinIBA
11/2023 - 08/2022
2carbopol 940 (sodium polyacrylate)IBA
01/2023 - 06/2022
2Proteins (Proteins, Gene)FDA Link
08/2022 - 04/2012
2cuminaldehydeIBA
07/2022 - 06/2022
2Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 01/2016
2IonsIBA
12/2020 - 07/2019
2N-Acetylneuraminic Acid (Sialic Acid)IBA
07/2019 - 07/2019
2CholesterolIBA
09/2017 - 04/2012
2SilverIBA
02/2016 - 01/2016
2CopperIBA
02/2012 - 12/2011
2Streptozocin (Streptozotocin)FDA Link
06/2010 - 04/2010
2NF-kappa B (NF-kB)IBA
06/2010 - 06/2009
2Caspase 3 (Caspase-3)IBA
04/2010 - 06/2009
2Cytochromes c (Cytochrome c)IBA
04/2010 - 06/2009
2Cytochrome P-450 CYP2E1 (CYP2E1)IBA
03/2010 - 02/2010
1DNA (Deoxyribonucleic Acid)IBA
11/2023
1Nucleic AcidsIBA
11/2023
1ChitosanIBA
11/2023
1CarbonIBA
11/2023
1NanoconjugatesIBA
06/2022
1sialic acid receptorIBA
01/2022
1cadherin 5IBA
01/2022
1Free RadicalsIBA
09/2021
17-hydroxycoumarin (umbelliferone)IBA
11/2020
1AntigensIBA
01/2020
1benzeneboronic acidIBA
07/2019
1CurcuminIBA
07/2019
1Urea (Carbamide)FDA LinkGeneric
09/2017
1CreatinineIBA
09/2017
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2017
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2017
1locked nucleic acidIBA
01/2017
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2017
15,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
01/2017
1ceric oxide (cerium dioxide)IBA
01/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1Caspase 9IBA
01/2017
1Small Interfering RNA (siRNA)IBA
02/2016
1chromium hexavalent ionIBA
09/2015
1Androgen Receptors (Androgen Receptor)IBA
01/2015
1Arecoline (Arecolin)IBA
01/2015
1AlkaloidsIBA
01/2015
1Testosterone (Sustanon)FDA Link
01/2015
1GonadotropinsIBA
01/2015

Therapy/Procedure

9Therapeutics
12/2023 - 02/2016
3Oral Administration
09/2010 - 01/2009
2Drug Therapy (Chemotherapy)
02/2016 - 01/2014
2Radiotherapy
11/2014 - 01/2014
1Traditional Medicine (Folk Remedies)
01/2024
1Intravenous Injections
06/2022
1Phototherapy (Light Therapy)
10/2021
1Immunotherapy
01/2020
1Precision Medicine
01/2020
1Aftercare (After-Treatment)
02/2016